New hope for Tough-to-Treat blood cancer: DZD8586 trial opens
NCT ID NCT06539182
First seen Jan 03, 2026
Summary
This study tests a new drug called DZD8586 in 155 adults whose chronic lymphocytic leukemia or small lymphocytic lymphoma has returned or stopped responding to previous treatments. The goal is to see how well the drug shrinks tumors and what side effects it may cause. Participants take the drug alone, and researchers will also measure how much drug stays in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
RECRUITINGNanjing, Jiangsu, China
-
Research Site
RECRUITINGHefei, Anhui, China
-
Research Site
RECRUITINGBeijing, Beijing Municipality, 100053, China
-
Research Site
RECRUITINGBeijing, Beijing Municipality, 100191, China
-
Research Site
RECRUITINGGuangzhou, Guandong, 510280, China
-
Research Site
RECRUITINGGuangzhou, Guandong, 510515, China
-
Research Site
RECRUITINGZhengzhou, Henan, China
-
Research Site
RECRUITINGWuhan, Hubei, China
-
Research Site
RECRUITINGChangchun, Jilin, China
-
Research Site
NOT_YET_RECRUITINGDalian, Liaoning, China
-
Research Site
RECRUITINGShenyang, Liaoning, China
-
Research Site
RECRUITINGJinan, Shandong, China
-
Research Site
RECRUITINGLinyi, Shandong, China
-
Research Site
RECRUITINGShanghai, Shanghai Municipality, China
-
Research Site
RECRUITINGTaiyuan, Shangxi, China
-
Research Site
RECRUITINGTianjin, Tianjin Municipality, 300020, China
-
Research Site
RECRUITINGTianjin, Tianjin Municipality, 300060, China
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.